Back to Articles
49672026 Q2 / First HalfPrimeJGAAP

KOBAYASHI PHARMACEUTICAL (4967) FY2026 Q2 Earnings Report

For FY2026 Q2, revenue came to ¥70.7B (+2.5% year on year) and operating income ¥2.2B (-67.5%). The segment drivers and cash flow follow.

Raw Materials & Chemicals/Chemicals


Quick View

MetricCurrent PeriodSame Period Previous YearYoY
Revenue¥707.5B¥690.2B+2.5%
Operating Income¥21.6B¥66.5B−67.5%
Ordinary Income¥30.1B¥72.5B−58.5%
Net Income¥11.4B¥31.6B−64.0%
ROE0.5%1.5%-

Executive Summary

The second quarter of the fiscal year ending December 2026 was characterized by higher revenue but a substantial decline in earnings, with deteriorating profitability being the key feature. Revenue increased to ¥707.5B (+2.5% YoY), while Operating Income fell sharply to ¥21.6B (-67.5%), Ordinary Income to ¥30.1B (-58.5%), and Net Income attributable to owners of the parent to ¥11.4B (-64.1%). The primary factors were the substantial outpacing of revenue growth by the increase in SG&A expenses and the widening Operating Loss in the International Business, which placed pressure on company-wide earnings.

Factors Affecting Financial Performance

【Revenue】Revenue of ¥707.5B represented a 2.5% YoY increase. The International Business was the growth driver, increasing 8.1%; by region, China grew 34.0% and Southeast Asia grew 12.4%, while the United States declined 8.5%, resulting in mixed performance across regions. The Domestic Business remained resilient, increasing 1.8%, and domestic sales accounted for approximately 77% of the sales mix on a segment-reporting basis.

【Profit and Loss】Operating Income of ¥21.6B (-67.5% YoY) was primarily attributable to the decline in the gross profit margin from 52.4% to 51.4%, together with a 5.6pt increase in the SG&A ratio from 42.7% to 48.3%. Ordinary Income of ¥30.1B (-58.5%) was supported by non-operating income and expenses, net (+¥8.5B), but this was insufficient to offset the decline in Operating Income. Net Income of ¥11.4B (-64.1%) declined substantially despite an improvement in extraordinary income and expenses, net, to -¥7.9B from -¥30.0B in the previous year. The decline in Profit Before Tax and the increase in the effective tax rate, from approximately 25.5% to 48.7%, contributed to the decrease. In conclusion, the current period resulted in higher revenue but lower earnings.

Segment Analysis

By segment, the Domestic Business generated revenue of ¥546.2B (+1.8% YoY) and Operating Income of ¥42.9B (-47.6%), maintaining profitability despite lower earnings, with a profit margin of 7.9%. The International Business generated revenue of ¥191.9B (+8.1%) but recorded an Operating Loss of ¥21.8B, representing a wider loss YoY and a profit margin of -11.3%; profitability deteriorated despite higher revenue. The Other Businesses generated revenue of ¥34.0B (+9.5%) and Operating Income of ¥1.3B (+92.8%), showing improvement despite their small scale. By region, sales to external customers were ¥520.0B in Japan (+0.7%), ¥72.2B in the United States (-8.5%), ¥49.5B in China (+34.0%), ¥40.0B in Southeast Asia (+12.4%), and ¥22.3B in other regions (+19.2%). Growth in China and Southeast Asia contributed to overall revenue growth, while the deterioration in the International segment’s earnings appears to have been affected by lower revenue in the U.S. Business and upfront investments. Both segments are undergoing profitability adjustments, with margins narrowing in the Domestic Business and the loss widening in the International Business.

Key Financial Indicators

【Profitability】The Operating Margin was 3.1%, down 6.5pt from 9.6% in the previous year. The Ordinary Income Margin was 4.3% versus 10.5% in the previous year, and the Net Profit Margin attributable to owners of the parent was 1.6% versus 4.6%; all margins contracted, indicating generally weaker profitability. 【Cash Flow Quality】Operating Cash Flow was limited to ¥4.6B, and its ratio to Net Income of ¥11.4B was approximately 0.4x, indicating weak earnings-to-cash conversion. The OCF-to-EBITDA ratio was also low at approximately 7%, based on EBITDA of approximately ¥62.0B. 【Investment Efficiency】ROE was 0.5%, reflecting the decline in Net Income and sluggish Total Asset Turnover due to an increase in inventories. 【Financial Soundness】The Equity Ratio was 83.2%, while the Current Ratio was approximately 328% (Current Assets of ¥1,248.3B / Current Liabilities of ¥380.7B), indicating an extremely strong financial base and a low degree of dependence on interest-bearing debt.

Cash Flow Analysis

Operating Cash Flow was ¥4.6B. The positive contribution from depreciation and amortization of ¥40.3B was offset by an increase in inventories (-¥67.9B) and corporate income tax payments (-¥20.3B). Although the decline in trade receivables generated a cash inflow of +¥184.0B, OCF remained only slightly positive overall. Investing Cash Flow was -¥102.2B, primarily reflecting capital expenditures of -¥101.4B, indicating that active investment continued. Financing Cash Flow was -¥45.9B, mainly due to cash outflows for dividend payments. As a result, Free Cash Flow (OCF + Investing CF) was -¥97.6B; investment and dividends could not be funded by OCF, and cash and deposits decreased by -¥152.9B (-24.5%) from the end of the previous year. The buildup of inventories and front-loaded investment placed pressure on liquidity, which was the key cash flow feature of the current period.

Quality of Earnings

Current-period earnings were affected not only by recurring operating results but also by extraordinary income and expenses, net of -¥7.9B. Extraordinary income of ¥8.5B primarily included a gain on the sale of investment securities of ¥4.6B, while extraordinary losses totaled ¥16.4B. The impact of extraordinary items improved from the previous year’s net amount of -¥30.0B. Non-operating income and expenses, net, amounted to +¥8.5B, with items such as dividend income of ¥3.0B contributing, but these were small relative to revenue and did not constitute a core earnings pillar. Corporate income taxes of ¥10.8B were recorded against Profit Before Tax of ¥22.2B, resulting in an effective tax rate of approximately 48.7%, a significant increase from approximately 25.5% in the previous year and one of the key factors compressing Net Income. Comprehensive Income was ¥31.0B, exceeding Net Income of ¥11.4B by ¥19.6B. Most of this difference consisted of the unrealized foreign exchange-related factor of +¥24.9B in foreign currency translation adjustments and therefore does not directly indicate operating earnings power. Given that OCF was below Net Income, there was a certain divergence between reported earnings and cash flow, and the quality of earnings had weakened somewhat compared with the previous year.

Earnings Forecast and Guidance

Progress toward the full-year forecast—Revenue of ¥1,730.0B, Operating Income of ¥125.0B, Ordinary Income of ¥130.0B, and Net Income of ¥100.0B—was 40.9% for Revenue, 17.3% for Operating Income, 23.2% for Ordinary Income, and 11.4% for Net Income, all substantially below the 50% mark implied by simple pro rata allocation. The delay in progress, particularly for earnings indicators, was pronounced. This implies that the second half must generate approximately ¥1,022.5B in Revenue and approximately ¥103.4B in Operating Income, requiring the second-half Operating Margin to improve substantially to approximately 10.1% from the first-half result of 3.1%. As of the current quarter, neither the earnings forecast nor the dividend forecast had been revised, and the full-year plan remained unchanged.

Shareholder Returns

The interim dividend was ¥45 per share, an increase of +¥1 from ¥44 in the same period of the previous year. The full-year dividend forecast remained unchanged at ¥106, implying a Payout Ratio of approximately 78.8% based on the full-year forecast EPS of ¥134.52. Because realized earnings as of the first half are smaller than full-year earnings due to seasonality and other factors, it is appropriate to use the full-year Payout Ratio as the reference. Recovery of earnings in the second half is therefore a prerequisite for achieving the plan. No information regarding share repurchases was provided.

Risk Factors

  1. Deterioration in International Business profitability: The International segment recorded an Operating Loss of ¥21.8B, representing a wider loss YoY and a profit margin of -11.3%. Profitability deteriorated despite higher revenue, weighing on the company-wide profit margin.

  2. Increase in inventories and weaker cash conversion: Inventories increased 41.6% YoY, while OCF remained at approximately 0.4x Net Income, indicating that deterioration in working capital was affecting cash-generation capacity.

  3. Hurdle to achieving the full-year plan: First-half progress toward the Operating Income forecast was only 17.3%, implying that an Operating Margin of approximately 10.1% will be required in the second half. This assumes a substantial improvement from the first-half result of 3.1%.

Industry Benchmark (Reference; Compiled by the Company)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Margin3.1%9.7% (5.4%–23.7%)−6.6pt
Net Profit Margin1.6%5.4% (1.3%–20.1%)−3.8pt
The company’s profitability was below the industry median. In particular, its Operating Margin was below the lower bound of the industry IQR of 5.4%.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (YoY)2.5%10.6% (-3.4%–25.4%)−8.1pt
Revenue growth was also below the industry median but remained within the industry IQR.

※Source: Compiled by the Company

Key Points from the Financial Results

  1. The increase in the SG&A ratio from 42.7% to 48.3% was the primary factor behind the decline in the Operating Margin. The linkage between cost effectiveness and revenue growth will be the focus of future profitability recovery.

  2. The increase in the effective tax rate from approximately 25.5% to 48.7% caused Net Income to decline more sharply than Ordinary Income. Trends in the tax burden will be an important factor affecting Net Income.

  3. Most of the difference between Comprehensive Income of ¥31.0B and Net Income of ¥11.4B was attributable to foreign currency translation adjustments. This factor should be evaluated separately from improvements in operating profit and loss.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type, with an explicit five-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

ScenarioTheoretical Share Price
bear¥2,528
base¥2,561
bull¥2,588
Calculation AssumptionValue
Book Value Per Share (BPS)¥2,821
Adjusted Forecast EPS¥164.3
Cost of Equity r9.27% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 0.50%)
Residual Income Persistence Coefficient ω / Explicit Forecast Period0.62 / 5 years
Assumed Payout Ratio78.8%
Forecast EPS Confidence Adjustment×1.075 (based on the industry’s historical guidance achievement rate)
Implied PBR / PER0.91x / 15.6x

Sensitivity: ¥2,493–¥2,632 at Cost of Equity ±1%; ¥2,553–¥2,566 at ω ±0.1.

Notes:

  • Goodwill amortization of ¥19.8 per share has been added back to earnings (for non-cash expense treatment and comparability with IFRS companies).
  • Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
  • Net assets as of the quarter-end have been used; there is a timing difference relative to the full-year forecast.
  • Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest rate reference month: 2026-07 / This value does not predict or guarantee the future share price.)


This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting professionals as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

FY2026 Q2 performance was weak: modest top-line growth was overwhelmed by a sharp deterioration in operating profitability and cash conversion. Revenue rose 2.5% year on year to ¥70.75bn. Gross profit was broadly stable at ¥36.33bn, but the gross margin declined by 102bp to 51.4%. SG&A expense increased 15.8% year on year to ¥34.17bn, far exceeding revenue growth. Consequently, operating income fell 67.5% to ¥2.16bn and the operating margin contracted 657bp to 3.1%. Ordinary income declined 58.5% to ¥3.01bn, supported in part by ¥0.59bn of interest and dividend income. Net income attributable to owners fell 64.1% to ¥1.14bn, producing EPS of ¥15.29. The net margin compressed from 4.6% in the prior-year period to 1.6%, a decline of approximately 300bp. Domestic operations remained profitable but saw segment profit nearly halve, while international operations recorded a wider loss. The international business delivered revenue growth, led by China and Southeast Asia, but its segment loss widened to ¥2.18bn. Operating cash flow was only ¥0.46bn, equivalent to 0.40x net income and 0.07x EBITDA, indicating weak conversion of accounting earnings into cash. Working-capital absorption, notably the inventory increase, was a primary cash-flow burden. Free cash flow was negative ¥9.76bn because capital expenditures of ¥10.14bn substantially exceeded operating cash generation. The balance sheet remains highly resilient, with a 327.9% current ratio, net cash resources, low 0.20x debt-to-equity, and an 82.9% capital adequacy ratio. However, the ¥45 interim dividend represents a 309.2% payout against first-half earnings and is not covered by free cash flow. Full-year guidance implies a material second-half recovery, especially in operating profit, making margin normalization, international-loss containment, inventory discipline, and operating cash-flow recovery the central execution requirements.

Profitability Analysis

The reported annualized DuPont ROE is 1.1%, decomposed into a 1.6% net profit margin, 0.562x asset turnover, and 1.20x financial leverage. The principal constraint is profitability rather than leverage: the capital structure is conservative, so financial leverage provides little amplification of returns. Net margin was the most materially impaired component, falling to 1.6% from approximately 4.6% in the prior-year period. This was driven by the operating margin decline to 3.1% from 9.6%, as SG&A rose 15.8% while revenue grew only 2.5%. Gross margin also fell to 51.4% from approximately 52.4%, indicating a 102bp deterioration in gross-profit conversion before the much larger SG&A-driven operating-margin compression. EBITDA was ¥6.20bn and the EBITDA margin was 8.8%, above the EBIT margin because depreciation and amortization totaled ¥4.03bn. Under JGAAP, goodwill amortization of ¥0.73bn reduced operating income and net income; this equals 11.8% of reported EBITDA and is a moderate, rather than immaterial, accounting drag when comparing with IFRS-reporting peers. EBITDA before goodwill amortization was ¥6.93bn. The tax burden was 0.511, corresponding to a 48.7% effective tax rate, well above a normal Japanese corporate tax burden and materially reducing the translation of pre-tax income into net income. Interest burden was 1.027 because non-operating income exceeded interest expense, while interest expense itself was only ¥0.10bn. Interest coverage of 216.2x and EBITDA interest coverage of 619.6x confirm that debt servicing is not a profitability issue. The annualized ROIC of 1.4% is also below the 5% warning threshold, suggesting current operating earnings are generating inadequate returns on the capital base. Domestic business is the core business by operating-income contribution, with segment profit of ¥4.29bn, but its segment margin declined to 7.9% from 15.3% a year earlier. International segment revenue increased 8.1% to ¥19.20bn including intersegment sales, but its segment loss widened to ¥2.18bn from a ¥1.50bn loss, with the segment margin weakening to negative 11.3% from negative 8.4%.

Growth Assessment

Revenue growth was modest at 2.5%, with a divergent geographic profile. External domestic revenue increased 0.5% to ¥52.00bn, indicating limited growth in the largest earnings contributor. International external revenue rose 8.2% to ¥18.40bn. Within international markets, China revenue increased 34.0% to ¥4.95bn, Southeast Asia increased 12.4% to ¥4.00bn, and other overseas markets increased 19.2% to ¥2.23bn. These gains were partly offset by an 8.5% decline in US revenue to ¥7.22bn. The revenue mix is therefore becoming somewhat more international, but the current growth mix is dilutive because the international segment remains loss-making. Domestic segment profit fell 47.6% to ¥4.29bn despite broadly stable revenue, highlighting a material cost or promotional-efficiency issue in the core business. Reported operating profit of ¥2.16bn includes the loss-making international business and was down much more sharply than revenue, indicating negative operating leverage. Full-year sales guidance is ¥173.0bn, and first-half progress is 40.9%, 9.1 percentage points below the standard 50% halfway progress rate but not beyond the stated 10-point deviation threshold. Operating-income progress is only 17.3% against the ¥12.5bn full-year target, 32.7 percentage points below the 50% reference point. Ordinary-income progress is 23.1% against guidance, and net-income progress is 11.4% against the ¥10.0bn target. Achieving guidance requires second-half revenue of ¥102.25bn, operating income of ¥10.34bn, and net income of ¥8.86bn. This implies a second-half operating margin near 10.1%, versus 3.1% in the first half, requiring a substantial recovery in SG&A efficiency and/or gross-margin performance. Management has not revised guidance, so the earnings trajectory will be assessed primarily against this demanding implied second-half profit recovery.

Financial Health

Financial health is strong despite weak earnings and cash-flow conversion. Current assets of ¥124.83bn exceed current liabilities of ¥38.07bn by ¥86.76bn, producing working capital of ¥86.76bn and a current ratio of 327.9%. The quick ratio of 273.2% remains well above 1.0x, supported by cash and deposits of ¥47.03bn and receivables of ¥34.13bn. There is no current-ratio warning and no maturity mismatch indicated by the available balance-sheet structure. Total liabilities are only ¥42.19bn, equal to 16.8% of total assets, while total equity is ¥209.70bn. Debt-to-equity is 0.20x, well below the 2.0x risk threshold. Lease obligations total ¥0.72bn across current and non-current maturities, which are modest relative to liquidity and equity. Cash and deposits declined from ¥62.31bn a year earlier to ¥47.03bn, consistent with the combination of negative free cash flow, investing outflows, and dividends. Accounts receivable declined 34.6% year on year to ¥34.13bn, which supports liquidity and reflects cash collection during the period. Inventory increased 41.6% year on year to ¥20.83bn, representing 8.3% of total assets and offsetting part of the receivables-related working-capital release. Finished goods disclosed at ¥20.83bn are elevated, while raw materials and work in process were ¥6.79bn and ¥2.32bn, respectively. The inventory build increases the risk of slower sell-through, discounting, obsolescence, or further working-capital use if demand does not absorb stock. Investment securities of ¥30.68bn represent 12.2% of total assets and provide financial asset support, although valuation movements can affect other comprehensive income and equity. Goodwill of ¥7.24bn equals only 3.5% of equity and 2.9% of assets, while total intangibles equal 6.6% of assets; neither indicates balance-sheet dependence on acquisition-related asset values. Deferred tax assets of ¥5.53bn are supported by the substantial equity base but should be monitored against the future earnings needed for recoverability.

Notable B/S Changes

Inventories: +¥6.12bn (+41.6%) to ¥20.83bn - sizeable stock build and key contributor to weak operating cash conversion; raises sell-through, obsolescence and discounting risk. Accounts receivable: -¥18.06bn (-34.6%) to ¥34.13bn - substantial collection-related release of working capital, although annualized DSO of 88 days remains above the 60-day warning level. Cash and deposits: -¥15.29bn (-24.5%) to ¥47.03bn - reflects negative free cash flow, ¥10.14bn capital expenditure and ¥4.46bn dividends, while remaining adequate relative to liabilities. Accounts payable and other payables: trade payables -¥0.57bn and other payables -¥14.44bn - reductions consumed operating cash and partially offset the large receivables collection benefit. Property, plant and equipment: +¥2.23bn (+3.3%) to ¥69.60bn, with construction in progress declining by ¥15.15bn to ¥2.51bn - indicates commissioning or transfer of an investment pipeline into operating assets alongside elevated capex. Goodwill: -¥0.47bn (-6.1%) to ¥7.24bn - consistent with ongoing JGAAP amortization; goodwill remains low at 3.5% of equity, limiting impairment sensitivity.

Cash Flow Quality

Cash-flow quality is the principal financial concern in the first half. Operating cash flow was only ¥0.46bn, down sharply from ¥142.06bn in the prior-year period. OCF/net income was 0.40x, below the 0.8x warning threshold, meaning only 40% of reported net income converted into operating cash flow. Cash conversion, measured as OCF/EBITDA, was 0.07x versus a 0.7x concern threshold, confirming that EBITDA did not translate into cash during the period. The low conversion reflects working-capital and other operating outflows despite a large ¥18.40bn cash inflow from lower trade receivables. Inventories consumed ¥6.79bn of cash, while trade payables declined by ¥4.43bn and other payables declined by ¥7.85bn. These reductions in supplier and other liabilities materially offset the receivables collection benefit and should be monitored because they may represent normalization of payment timing rather than a recurring cash source. The accruals ratio of 0.3% is below the 5% benchmark and does not, by itself, suggest elevated balance-sheet accrual risk. Nevertheless, the much weaker OCF than net income is a direct quality concern under the reported cash-flow measures. Capital expenditures were ¥10.14bn, equal to 2.51x depreciation and amortization of ¥4.03bn, demonstrating a significant investment phase rather than maintenance-only spending. CapEx represented 14.3% of first-half revenue, substantially above typical manufacturing reference ranges. Investing cash flow was negative ¥10.22bn, primarily reflecting this capital expenditure. Free cash flow was negative ¥9.76bn, compared with negative ¥0.90bn in the prior-year period. The company funded the shortfall from its substantial cash balance while also paying ¥4.46bn of dividends, resulting in a ¥13.90bn net decrease in cash. Sustained capex at this level requires a recovery in operating cash flow to avoid continued drawdown of cash resources.

Dividend Sustainability

The interim dividend is ¥45 per share, compared with ¥44 in the prior-year interim period. Based on first-half EPS of ¥15.29, the reported interim payout ratio is 309.2%, substantially above the 100% warning threshold. This level is not covered by first-half earnings and should be viewed as reliance on accumulated cash and retained earnings rather than current-period profit generation. First-half free cash flow was negative ¥9.76bn, so the dividend is also not covered by internally generated free cash flow; reported FCF coverage was negative 2.78x. Cash dividends paid were ¥4.46bn during the period. The balance sheet provides meaningful near-term support, with ¥47.03bn of cash and deposits and ¥200.92bn of retained earnings. Full-year DPS guidance is ¥106, comprising the ¥45 interim dividend and an implied ¥61 year-end dividend. Against forecast full-year EPS of ¥134.52, the implied full-year dividend payout ratio is approximately 78.8%. This is lower than the interim payout ratio but remains above the stated 60% sustainability reference point. The full-year dividend framework therefore depends heavily on achieving the forecast ¥10.0bn of attributable net income and restoring operating cash conversion in the second half. No share-buyback outflow is identified in the provided period data, so the analysis is confined to the dividend payout ratio rather than a total return ratio. Dividend sustainability is supported by capital strength in the near term, but recurring coverage is contingent on delivery of the implied second-half earnings and cash-flow recovery.

Risk Assessment

Business risks include Core domestic business profitability risk: domestic revenue was nearly flat at +0.5%, while segment profit fell 47.6% to ¥4.29bn and margin declined from 15.3% to 7.9%., International execution risk: international segment revenue increased 8.1%, but the segment loss widened to ¥2.18bn from ¥1.50bn; growth is currently earnings-dilutive., US demand and competitive-positioning risk: US revenue declined 8.5% year on year to ¥7.22bn, offsetting part of the strong China and Southeast Asia growth., Manufacturing inventory risk: inventory increased 41.6% year on year to ¥20.83bn, and reported annualized DIO measures of 110 days and 159 days both exceed the relevant warning benchmarks., Consumer-products demand, product-mix, promotional-spending and retailer inventory-adjustment risk: the large divergence between stable sales and sharply lower domestic segment profit indicates sensitivity to cost absorption and selling efficiency..

Financial risks include Cash-conversion risk: OCF/net income of 0.40x and OCF/EBITDA of 0.07x are below stated quality thresholds., Working-capital risk: annualized receivable days of 88 exceed the 60-day warning threshold, while elevated inventory days extend the reported cash conversion cycle to 205 days., Free-cash-flow risk: negative ¥9.76bn FCF resulted from only ¥0.46bn OCF against ¥10.14bn capex., Dividend-coverage risk: the ¥45 interim dividend has a 309.2% payout ratio against first-half profit and is not covered by FCF., Tax-rate risk: the 48.7% effective tax rate and 0.511 tax burden materially suppress net-income conversion from pre-tax income..

Key concerns include Highest priority is the gap between first-half operating income of ¥2.16bn and the ¥12.5bn full-year operating-income target, which requires ¥10.34bn in the second half., Operating efficiency is below benchmark, with a 3.1% EBIT margin versus the 5% concern threshold and annualized ROIC of 1.4% versus the 5% warning threshold., The reported 205-day cash conversion cycle is a material liquidity-efficiency concern even though absolute liquidity remains strong., The capital-investment program is sizable, at 2.51x depreciation, and requires disciplined project execution and subsequent cash returns., Goodwill impairment risk is currently limited: goodwill is 3.5% of equity and 1.17x EBITDA, both within healthy ranges, although JGAAP goodwill amortization remains a recurring earnings charge..

Investment Implications

Key takeaways include Revenue growth of 2.5% does not currently translate into earnings growth because SG&A expansion materially outpaced sales., The domestic segment remains the core earnings base, but its sharp margin decline is the most important operational issue., International growth is concentrated in China and Southeast Asia, but the widening international loss means profitability remediation is needed before this growth becomes value-accretive., The company has substantial liquidity and low leverage, providing capacity to absorb the current investment and cash-flow shortfall., Guidance credibility depends on a pronounced second-half improvement in operating margin, net income, and operating cash generation., The dividend is balance-sheet-supported in the near term but requires forecast delivery to regain earnings-based coverage..

Metrics to watch include Domestic segment margin and the pace of SG&A growth relative to revenue, International segment loss, especially US sales recovery and profitability in China and Southeast Asia, Operating margin versus the approximately 10.1% implied second-half margin needed to meet full-year guidance, Operating cash flow, OCF/net income, and OCF/EBITDA cash conversion, Inventory balance, inventory days, sell-through and any need for discounting or write-downs, Receivable days and the cash conversion cycle, CapEx deployment, capex-to-depreciation ratio, and resulting free cash flow, Effective tax rate and tax-burden normalization, Progress toward the ¥173.0bn sales, ¥12.5bn operating-income, and ¥10.0bn net-income forecasts.

Regarding relative positioning, Relative to typical profitable branded consumer-health and manufacturing businesses, the company is financially conservative and has a strong asset base, but its current 3.1% operating margin, 1.1% annualized ROE, 1.4% annualized ROIC, and 205-day cash conversion cycle indicate materially weaker current operating and capital efficiency. Acquisition-related balance-sheet risk is low, as goodwill and intangibles are modest relative to equity and assets.